1,5-anhydroglucitol monitoring in diabetes: A mass balance perspective

被引:14
|
作者
Nerby, Craig L. [1 ]
Stickle, Douglas F. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA
关键词
1,5-anhydroglucitol; Diabetes; ORAL GLUCOSE-TOLERANCE; TERM GLYCEMIC CONTROL; CHRONIC-RENAL-FAILURE; SERUM 1,5-ANHYDROGLUCITOL; PLASMA 1,5-ANHYDRO-D-GLUCITOL; CEREBROSPINAL-FLUID; URINARY-EXCRETION; CLINICAL MARKER; MELLITUS; EXCURSIONS;
D O I
10.1016/j.clinbiochem.2008.08.086
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
1,5-anhydroglucitol (AG) is a nonmetabolizable glucose analogue found in plasma due to ingestion. The normal steady-state concentration can be dramatically decreased by inhibition of tubular reabsorption during periods of hyperglycemia. For this reason, monitoring of AG has been plausibly advocated for detection of periodic glucosuric hyperglycemia. In this review, we examine the influence of variation in factors affecting both steady-state and transient changes in plasma AG. Among normals, the lower and upper limits of the plasma AG reference range vary by a factor of 5. Using a simplified mass balance model (a single compartment model with 3-6x larger-than-plasma volume of distribution), reasonable inter-individual variations of ingestion rate, glomerular filtration rate and fractional post-filtration reabsorption are each able to account for the wide range of normal, steady-state AG concentrations. In monitoring of changes in AG, inter-individual variations in the threshold for glucose excretion, volume of distribution and glomerular filtration rate are all likely to significantly affect correspondence of integral changes in AG to integral glucosuria/ hyperglycemia. This combination of variables, affecting both steady-state and transient changes, is significantly confounding with respect to interpretation of serial plasma AG concentrations. Resolution of information content of AG monitoring is thus largely that of crossing simple characterization of deltas [+,0,-] for changes in AG concentration against the information content of hemoglobin Alc monitoring. Despite this limitation, AG monitoring can in principle provide information about glycemic control in the short term that is not apparent through monitoring of hemoglobin Alc alone. However, whether AG monitoring can lead to improved outcomes in diabetes management remains to be established. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [41] DECREASED PLASMA 1,5-AG (1,5-ANHYDROGLUCITOL) CONCENTRATIONS IN DIABETES-MELLITUS AND RENAL GLYCOSURIA
    KAWAZU, S
    NEGISHI, K
    SUZUKI, M
    ISHII, J
    YAMANOUCHI, T
    AKANUMA, H
    YABUUCHI, M
    AKANUMA, Y
    DIABETOLOGIA, 1989, 32 (07) : A502 - A502
  • [42] Serum 1,5-anhydroglucitol is a strong predictor of the postprandial hyperglycemia in type 2 diabetes patients
    Kawasaki, I
    Sato, T
    Hosoi, M
    Yoshioka, KS
    Yamakita, T
    Fukumoto, M
    Tanaka, N
    Matsuyama, H
    Ueda, M
    Fujii, S
    DIABETES, 2005, 54 : A76 - A76
  • [43] Evaluation of 1,5-Anhydroglucitol as a Marker for Glucose Variability in Patients with Type 2 Diabetes Mellitus
    Kim, Min Joo
    Bo, Yul Hwang
    Yoon, Ji Won
    Kim, Hong Il
    Kwak, Soo Heon
    Cho, Sun Wook
    Kang, Shinae
    Jung, Hye Seung
    Kim, Seong Yeon
    Lim, Soo
    Jang, Hak Chul
    Park, Kyong Soo
    DIABETES, 2010, 59 : A138 - A138
  • [44] Determination of glycemic monitoring marker 1,5-anhydroglucitol in plasma by liquid chromatography-electrospray tandem mass spectrometry
    Li, Shuijun
    Heng, Xiaoxiang
    Sheng, Hongguang
    Wang, Yiping
    Yu, Chen
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 875 (02): : 459 - 464
  • [45] Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus
    Kim, Min Joo
    Jung, Hye Seung
    Hwang-Bo, Yul
    Cho, Sun Wook
    Jang, Hak Chul
    Kim, Seong Yeon
    Park, Kyong Soo
    ACTA DIABETOLOGICA, 2013, 50 (04) : 505 - 510
  • [46] Circulating 1,5-anhydroglucitol levels in adults patients with diabetes reflect longitudinal changes of glycemia
    McGill, JRB
    Cole, TG
    Nowatzke, W
    Houghton, S
    Ammirati, EB
    Gautille, T
    Sarno, MJ
    DIABETES CARE, 2004, 27 (08) : 1859 - 1865
  • [47] 1,5-anhydroglucitol and postprandial hyperglycemia as assessed by self-monitoring of blood glucose in Japanese patients with moderately controlled diabetes
    Akutsu, Toshie
    Mori, Yutaka
    Itoh, Yohta
    Tajima, Naoko
    DIABETES, 2007, 56 : A112 - A113
  • [48] IDENTIFICATION OF 1,5-ANHYDROGLUCITOL IN THIN-LAYER CHROMATOGRAMS
    PITKANEN, E
    PUROKOSKI, S
    LAJUNEN, K
    MIETTINEN, U
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1980, 40 (01): : 95 - 97
  • [49] COMPARISON OF 1,5-ANHYDROGLUCITOL, HBA1C, AND FRUCTOSAMINE FOR DETECTION OF DIABETES-MELLITUS
    YAMANOUCHI, T
    AKANUMA, Y
    TOYOTA, T
    KUZUYA, T
    KAWAI, T
    KAWAZU, S
    YOSHIOKA, S
    KANAZAWA, Y
    OHTA, M
    BABA, S
    KOSAKA, K
    DIABETES, 1991, 40 (01) : 52 - 57
  • [50] 1,5-Anhydroglucitol as a Marker of Hyperglycemic Excursions Defined by Continuous Glucose Monitoring in Older Adults
    Malek, Natalie D.
    Fang, Michael
    Shin, Jung-Im
    Coresh, Joe
    Pankow, Jim S.
    Lutsey, Pamela L.
    Valint, Arielle
    Echouffo, Justin B.
    Selvin, Elizabeth
    CIRCULATION, 2024, 149